Proteimax BIO Technology

Company Overview

Snapshot

Founded in December 2025, Proteimax BIO Technology operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing biologically active peptide solutions.

Business overview

Proteimax BIO Technology is a Health Tech & Life Sciences company specializing in the discovery and commercialization of naturally occurring intracellular peptides. Its core product, Pep19, is formulated as a functional food ingredient designed to reduce visceral fat, improve metabolic markers, and enhance sleep quality. The company is also developing additional peptide candidates for cell proliferation and neuroprotection. Proteimax partners with food, beverage, supplement manufacturers, and animal health companies to integrate its proprietary peptides into products for human and companion animal health, operating within the Pharma & Medical Biotechnology and Drugs Discovery & Development sectors.

Company Intelligence Q&A

What is Proteimax BIO Technology's primary focus?

Proteimax BIO Technology focuses on discovering and commercializing naturally occurring intracellular peptides to address health and agricultural challenges, developing solutions for both human and animal health.

What is the lead peptide product developed by Proteimax BIO Technology?

The company's lead peptide, Pep19, is formulated as a functional food ingredient aimed at reducing visceral fat, improving metabolic markers, and enhancing sleep quality.

Which markets does Proteimax BIO Technology serve?

Proteimax BIO Technology serves the food, beverage, and supplement industries, as well as the animal health sector, by integrating its peptides into various products.

What stage of development are Proteimax BIO Technology's products in?

Proteimax BIO Technology's products are currently in the Clinical Trial stage, supported by preclinical work and early-stage clinical data.

When was Proteimax BIO Technology founded?

Proteimax BIO Technology was founded in December 2025.